Our Team
Leadership Team
Board of Directors
Scientific Advisory Board
Investors
Partners
We are advancing and expanding our innovative small molecule RNA modulation pipeline to offer treatment options for patients with unmet medical needs across a wide range of therapeutic areas. One-way Rgenta can extend its positive impact on patients' lives is by harnessing the power of its platform through collaboration. We recognize that by establishing collaborative partnerships with companies, universities and research institutions, we can create exceptional science together and accelerate our discovery and development efforts to benefit patients. We welcome you to contact us about becoming an Rgenta partner.
